ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023, at 8:30 a.m. ET

Rhea-AI Summary

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) will announce its fourth quarter and full year 2022 financial results on March 9, 2023, before the market opens. The call will include insights from Nikhil Lalwani, CEO, and Stephen P. Carey, CFO, at 8:30 a.m. ET. Interested parties can participate via a conference call at 800-343-5172 or through a webcast available on the ANI website. Following the call, a replay will be accessible for two weeks. ANI Pharmaceuticals focuses on developing high-quality branded and generic pharmaceuticals, particularly in addressing high unmet medical needs.

Positive

• Scheduled announcement of Q4 and full year 2022 financial results indicates transparency.
• Focus on developing high-quality branded and generic pharmaceuticals may lead to growth.

Negative

• None.

BAUDETTE, Minn.--(BUSINESS WIRE)-- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its fourth quarter and full year 2022 financial results on Thursday, March 9, 2023, prior to market open.

Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, will host a conference call to discuss the results as follows:

Date		Thursday, March 9, 2023
Time		8:30 a.m. ET
Toll free (U.S.)		800-343-5172
Webcast (live and replay)		www.anipharmaceuticals.com, under the “Investors” section

A replay of the conference call will be available within two hours of the call’s completion and will remain accessible for two weeks by dialing 800-934-8367 and entering access code 2895031.

About ANI

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin^® Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230222005924/en/

Investor Relations:

Lisa M. Wilson, In-Site Communications, Inc.

212-452-2793

lwilson@insitecony.com

Source: ANI Pharmaceuticals, Inc.

FAQ

When will ANI Pharmaceuticals announce its Q4 2022 financial results?

ANI Pharmaceuticals will announce its Q4 2022 financial results on March 9, 2023.

What time is the ANI Pharmaceuticals conference call?

The conference call will take place at 8:30 a.m. ET on March 9, 2023.

How can I listen to the ANI Pharmaceuticals earnings call?

You can listen to the ANI Pharmaceuticals earnings call by dialing 800-343-5172 or via webcast on their website.

What is ANI Pharmaceuticals' stock symbol?

ANI Pharmaceuticals' stock symbol is ANIP.